174 related articles for article (PubMed ID: 17894017)
41. Antiphospholipid syndrome in a young Nigerian girl presenting with gangrenous toes.
Anakwue RC; Chijioke C; Mbah A; Onuh A; Okwara C
Cardiovasc J Afr; 2013 Oct; 24(9-10):e8-e11. PubMed ID: 24337244
[TBL] [Abstract][Full Text] [Related]
42. Kidney disease associated with primary antiphospholipid syndrome: clinical signs and histopathological features in an case experience of five cases.
Saracino A; Ramunni A; Pannarale G; Coratelli P
Clin Nephrol; 2005 Jun; 63(6):471-6. PubMed ID: 15960149
[TBL] [Abstract][Full Text] [Related]
43. Primary Antiphospholipid Syndrome with Livedo Reticularis is Linked to Female Sex and Stroke and Negatively Associated with Thyroid Disease.
Carvalho JF; de Araujo RPC; Skare TL
Curr Rheumatol Rev; 2022; 18(4):352-356. PubMed ID: 34784875
[TBL] [Abstract][Full Text] [Related]
44. Zonal cortical scarring and tubular thyroidization in kidney biopsies of patients with SLE-histologic indicator for antiphospholipid antibodies.
Shah R; Brodsky SV; Hebert L; Rovin BH; Nadasdy T; Satoskar AA
Lupus; 2018 Dec; 27(14):2236-2244. PubMed ID: 30403144
[TBL] [Abstract][Full Text] [Related]
45. [Is the primary antiphospholipid syndrome a forerunner of SLE?].
Tarr T; Muzes G; Pitlik E; Lakos G; Csépány T; Soltész P; Zeher M; Szegedi G; Kiss E
Orv Hetil; 2005 Jan; 146(5):203-7. PubMed ID: 15773587
[TBL] [Abstract][Full Text] [Related]
46. [Dermatologic manifestations of the antiphospholipid syndrome].
Francès C; Barete S; Soria A
Rev Med Interne; 2012 Apr; 33(4):200-5. PubMed ID: 22078802
[TBL] [Abstract][Full Text] [Related]
47. Clinical manifestations and antiphosphatidylserine antibodies in patients with systemic lupus erythematosus: is there an association?
Sahin M; Duzgun N; Tunc SE; Tutkak H
Clin Rheumatol; 2007 Feb; 26(2):154-60. PubMed ID: 16598413
[TBL] [Abstract][Full Text] [Related]
48. Initial cutaneous manifestations associated with histopathological leukocytoclastic vasculitis in two patients with antiphospholipid antibody syndrome.
Kawakami T; Soma Y; Mizoguchi M
J Dermatol; 2005 Dec; 32(12):1032-7. PubMed ID: 16471472
[TBL] [Abstract][Full Text] [Related]
49. Antiphospholipid-mediated thrombosis: interplay between type of antibodies and localisation of lung, and cardiovascular incidences in primary antiphospholipid syndrome.
Stojanovich L; Djokovic A; Kontic M
Clin Exp Rheumatol; 2015; 33(4):531-6. PubMed ID: 26088955
[TBL] [Abstract][Full Text] [Related]
50. Ferritin in the antiphospholipid syndrome and its catastrophic variant (cAPS).
Agmon-Levin N; Rosário C; Katz BS; Zandman-Goddard G; Meroni P; Cervera R; Stojanovich L; Blank M; Pierangeli S; Praprotnik S; Meis Ed; Seguro LP; Ruffatti A; Pengo V; Tincani A; Doria A; Shoenfeld Y
Lupus; 2013 Nov; 22(13):1327-35. PubMed ID: 24036580
[TBL] [Abstract][Full Text] [Related]
51. Aortitis in the setting of catastrophic antiphospholipid syndrome in a patient with systemic lupus erythematosus.
González-García A; López-Rodríguez M; Redondo S; Patier JL; Masso P; Tenorio M; Fajardo GS; Sarhane Y; Lacalzada MM; Manzano L
Lupus; 2020 Aug; 29(9):1126-1129. PubMed ID: 32517572
[TBL] [Abstract][Full Text] [Related]
52. The antiphospholipid antibody syndrome: diagnosis, skin manifestations and current therapy.
Asherson RA; Francès C; Iaccarino L; Khamashta MA; Malacarne F; Piette JC; Tincani A; Doria A
Clin Exp Rheumatol; 2006; 24(1 Suppl 40):S46-51. PubMed ID: 16466624
[TBL] [Abstract][Full Text] [Related]
53. Catastrophic antiphospholipid syndrome (CAS): a rare manifestation of the antiphospholipid antibody syndrome.
Mazzucchelli R; Barbadillo C; Youssef H; Bernaldo de Quiros LB; Mulero J; Andreu-Sanchez JL
Clin Exp Rheumatol; 1993; 11(6):653-7. PubMed ID: 8299260
[TBL] [Abstract][Full Text] [Related]
54. Evolution of cardiac dysfunction in patients with antiphospholipid antibodies and/or antiphospholipid syndrome: a 10-year follow-up study.
Kampolis C; Tektonidou M; Moyssakis I; Tzelepis GE; Moutsopoulos H; Vlachoyiannopoulos PG
Semin Arthritis Rheum; 2014 Feb; 43(4):558-65. PubMed ID: 24012042
[TBL] [Abstract][Full Text] [Related]
55. Catastrophic antiphospholipid syndrome: a rare cause of disseminated microvascular thrombotic injury - a case report with pathological and molecular correlative studies.
Lai S; Walker DH; Elghetany MT
Pathol Int; 2005 Mar; 55(3):144-9. PubMed ID: 15743323
[TBL] [Abstract][Full Text] [Related]
56. Antiphospholipid antibodies and retinal vascular disease.
Dunn JP; Noorily SW; Petri M; Finkelstein D; Rosenbaum JT; Jabs DA
Lupus; 1996 Aug; 5(4):313-22. PubMed ID: 8869905
[TBL] [Abstract][Full Text] [Related]
57. [Anticardiolipin antibody in peripheral arterial diseases].
Meyer O
Arch Mal Coeur Vaiss; 1991 Nov; 84(11 Suppl):1645-51. PubMed ID: 1768182
[TBL] [Abstract][Full Text] [Related]
58. Gangrene and Livedo Reticularis in Antiphospholipid Syndrome.
Freire de Carvalho J; Shoenfeld Y
Isr Med Assoc J; 2021 Sep; 23(9):601-602. PubMed ID: 34472238
[No Abstract] [Full Text] [Related]
59. Thrombotic cerebral arteriopathy in patients with the antiphospholipid syndrome.
Hughson MD; McCarty GA; Sholer CM; Brumback RA
Mod Pathol; 1993 Nov; 6(6):644-53. PubMed ID: 8302806
[TBL] [Abstract][Full Text] [Related]
60. Primary antiphospholipid syndrome as the forerunner of systemic lupus erythematosus.
Tarr T; Lakos G; Bhattoa HP; Szegedi G; Shoenfeld Y; Kiss E
Lupus; 2007; 16(5):324-8. PubMed ID: 17576733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
